ELEVATE Study: Design

Opinion
Video

Hope S. Rugo, MD, FASCO, discusses how the phase 3 ELEVATE study evaluates the combination of elacestrant with abemaciclib in patients with ER+/HER2– advanced or MBC who have progressed on prior endocrine therapy.

Recent Videos
4 experts are featured in this series.
Hope S. Rugo, MD, FASCO, is featured in this series.
1 expert in this video